Atlas Trials

Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Clinical trial NCT00896675 · COMPLETED

Trial details

NCT number
NCT00896675
Sponsor
Vanderbilt-Ingram Cancer Center
Status
COMPLETED
Study type
OBSERVATIONAL
Head and Neck Cancer
Start date
2007-06-01
Primary completion
2008-12-01
Enrollment
352

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.